XNAS: DSGN
Design Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Design Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the research and development of GeneTAC molecules, which are a novel class of small-molecule gene targeted chimera therapeutic candidates designed to be disease-modifyin...
Read More
12.22
-0.35
(-2.78%)
77,858.0
XNAS Volume
XNAS 20 Jul, 2026 11:22 AM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Design Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..